Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Ltd has announced its continued growth and expansion plans, highlighting a significant increase in its contracted annual recurring revenue and a strong customer retention rate. The company is poised for a major international expansion, particularly in the US market, pending FDA clearance for its PainChek Adult app. Additionally, PainChek has launched a new application targeting infants, tapping into a substantial market opportunity.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, offering an AI-enabled SaaS platform designed to assess and monitor pain in non-communicative populations via a smartphone app. The company focuses on markets in Australia, New Zealand, the UK, and Canada, with plans for significant international expansion.
Average Trading Volume: 1,758,745
Technical Sentiment Signal: Buy
Current Market Cap: A$73.68M
Learn more about PCK stock on TipRanks’ Stock Analysis page.